Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-10-15EMA Authorised: Zutectra (human hepatitis B immunoglobulin) — Biotest Pharma GmbH
The European Medicines Agency has authorised Zutectra, a human hepatitis B immunoglobulin, for passive immunization in hepatitis B infection…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Exact Sciences is reporting on the performance of a multi-target hepatocellular carcinoma test in individuals at increased risk. The clinica…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease [Phase 1]
Phase 1 study evaluating blood levels of Bepirovirsen in adults with severe or moderate kidney disease. The sponsor is GlaxoSmithKline and t…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Reducing Vertical Transmission of Hepatitis B in Africa [Phase 3]
A Phase 3 clinical trial to reduce vertical transmission of Hepatitis B in Africa is underway. It is sponsored by the University of Alabama …
-
CLINICAL_TRIALS other · 2025-10-06Clinical Trial Update: Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Clinical trial update indicating long-term outcomes of antiviral therapies for chronic hepatitis B are being studied; the trial is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B [Phase 4]
A Phase 4 clinical trial is evaluating whether safely discontinuing antiviral therapy is possible in adults with chronic hepatitis B, and th…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Study of LW231 in Participants With Chronic Hepatitis B [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial of LW231 for chronic hepatitis B, with recruiting status and sponsor Shanghai Longwood Biopharmaceuticals C…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B [Phase 2, Phase 3]
A Phase II/III study of Hepenofovir Fumarate Tablets (HTS) for chronic hepatitis B is ongoing, with status shown as active but not currently…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion [EARLY_Phase 1]
Early-phase 1 trial update evaluating the immunogenicity and safety of TVAX-008 injections in chronic hepatitis B patients with low or negat…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Immune Dynamics in the Natural History of Chronic HBV Infection
A recruiting clinical trial is investigating immune dynamics in the natural history of chronic hepatitis B virus infection, sponsored by Nan…
-
EMA approval · 2025-09-29EMA Authorised: Hexyon (filamentous haemagglutinin;Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate);hepatitis B surface antigen;pertussis toxoid;poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells;poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells;poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells;tetanus protein;tetanus toxoid adsorbed on aluminium hydroxide, hydrated;Diphtheria toxoid) — Sanofi Winthrop Industrie
EMA authorised Hexyon, a hexavalent vaccine combining protection against hepatitis B, diphtheria, tetanus, pertussis, Haemophilus influenzae…
-
EMA approval · 2025-09-29EMA Authorised: Hexacima (hepatitis B surface antigen;Diphtheria toxoid;Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin;poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett);Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) conjugated to Tetanus protein;tetanus toxoid) — Sanofi Winthrop Industrie
The European Medicines Agency authorised Hexacima, a hexavalent vaccine combining hepatitis B surface antigen, diphtheria toxoid, pertussis …
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B [Phase 1]
This Phase 1 clinical trial evaluated the safety and immunogenicity of a naked DNA-based vaccine therapy in adults with chronic hepatitis B.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B [Phase 1]
This document reports a Phase 1 study to evaluate safety and antiviral activity of PBGENE-HBV in adults with chronic hepatitis B. The trial …
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients [Phase 1, Phase 2]
A research update describing a Phase 1/2 clinical trial to evaluate the safety and efficacy of AHB-137 in healthy participants and patients …
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe [NA]
This clinical trial update reports the completion of a study evaluating point-of-care diagnostics for sexually transmitted infections and an…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB) [Phase 2]
A Phase 2 study evaluating AHB-137 in treatment-naive adults with chronic hepatitis B is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B [Phase 2]
This update reports on a multicenter, randomized, double-blind, placebo-controlled Phase II study of TVAX-008 for chronic hepatitis B. The t…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand [Phase 3]
Phase 3 study evaluating the DTwP-HepB-Hib-IPV (SHAN6) vaccine administered with routine vaccines in healthy infants and toddlers in Thailan…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection [Phase 1, Phase 2]
A randomized, controlled Phase 1/Phase 2 trial evaluating a vaccine therapy for chronic hepatitis B infection. The study is currently not ye…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B [Phase 2]
Phase 2 trial evaluating multiple combination therapies for chronic hepatitis B; the study has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection [Phase 1, Phase 2]
This clinical trial update notes that HT-101 and HT-102 are being studied in Phase 1/Phase 2 for chronic hepatitis B, and the trial status i…
-
CLINICAL_TRIALS other · 2025-09-19Clinical Trial Update: Liver Disease and Other Systemic Diseases
A recruiting clinical trial sponsored by Taipei Tzu Chi Hospital and Buddhist Tzu Chi Medical Foundation is studying liver diseases and rela…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients [Phase 2]
A multicenter Phase II randomized trial evaluating TVAX-008 injection for chronic Hepatitis B (HBV infection) is currently active but not re…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
An observational study of patients with chronic hepatitis B infection has been terminated.